Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia

Indian Journal of Pediatrics

Volumn 74, Issue 3, 2007, Pages 255-263

  Settin, A ^a   Al Haggar, M ^a   Al Dosoky, T ^a   Al Baz, R ^a   Abdelrazik, Nabil M ^b   Fouda, M ^b   Aref, S ^b   Al Tonbary, Y ^b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Childhood leukemia; Cytogenetic; Prognosis

Indexed keywords

BIOLOGICAL MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW EXAMINATION; CHILD; CHROMOSOME 10P; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 12Q; CHROMOSOME 17; CHROMOSOME 22; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HUMAN; IMMUNOPHENOTYPING; INFANT; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MONOSOMY X; REMISSION; TRISOMY 16; TRISOMY 21; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; GENETICS; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PROGNOSIS;

EID: 34249776094     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0040-z     Document Type: Article

References (66)

1. Friedmann AM and Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. The Oncologist 2000; 5:321-328.
2. Hashino S. and Imamura M. Clinical application of gene technology for diagnosis and treatment of leukemia. Rinsho-Byori 1997 Jan; 45(1):58-65. (Japanese).
3. Heim S and Smeland EB. Molecular genetic diagnosis of leukemia and lymphoma. Tidsskr Nor Laegeforn Gun 1998; 118(16):2511-2518.
4. Donadieu J, Hill C. Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review. Br J Haematol 2001; 115(1):34-45.
5. Avet-Loiseau H. FISH analysis at diagnosis in acute lymphoblastic leukemia. Leuk Lymphoma 1999; 33:441.
6. Joyce CA, Ross FM, Dennis NR et al. Multipaint FISH: a rapid and reliable way to define cryptic and complex abnormalities. Clin Genet 1999; 56:192-199.
7. Margolin JF. Poplack DG. Acute lymphoblastic leukemia. In Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia; Lippincott-Williams and Wilkin, 2002; 489-544.
8. SPSS. Statistical Package for Social Science, standard version 10.0, 1999; SPSS Inc., Chicago, IL.
9. Luken J. Acute lymphocytic leukemia. In Lee GR, Buthell TL, Athens JW and Leuken JN, eds. Wintrobe's Clinical Haematology. 9th edition. Philadelphia, London, Lea and Febiger, 1993; 1892-1919.
10. Steinherz PG, Gaynon PS, Breneman JC et al. Cytoreduction and prognosis in acute lymphoblastic leukemia; the importance of early marrow response: report from the Children's Cancer Group. J Clin Oncol 1996; 14:389-398.
11. Nachman J, Sather HN, Gaynon PS et al. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group. J Clin Oncol 1997; 15:2222-2230.
12. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clinl oncol 1996; 14(1):18-24.
13. Sather HN, Miller D, Nesbit M, et al: Difference in prognosis for boys and girls with acute lymphoblastic leukemia. Lancet 1981; 1:739.
14. Chessells JM, Richards SM, Bailey CC et al. Gender and treatment outcome in childhood lymphoblastic leukemia: report from the MRC UKALL trials. Br J Haematol 1995; 89(2): 364-372
15. Hemminki K and Li X. A population-based study of familial soft tissue tumors. J Clin Epidemiol 2001; 54(4):411-416.
16. Hammond D, Sather H, Nesbit M, et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Paediatr Oncol 1986; 14:124-134.
17. Eguiguren JM, Schell MJ, Crist WM et al. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992; 79:871.
18. Miller DR.: Acute lymphoblastic leukemia. Pediatr Clin North Am 1980; 27:269-275.
19. Ibrahim WN, Sabry FH, Saleh AI, et al. Surface markers analysis and correlation with FAB classification in Egyptian infants and children with acute lymphoblastic leukemia (ALL). Egypt J Haematol 1988; 13(1-2):19-25.
20. Baehner RL and Miller DR. Haematologic Malignancies: Leukemia and lymphoma. In Bacher, RL, Miller DR and Carnphel WM, eds. Blood diseases of infancy and childhood. 5th edition, Missouri; CV Mosby Company. 1984; 619-721.
21. Khalifa AS, Mokhtar GM, Gaballah M et al. Clinico-epidemiological study of acute childhood leukemia in Egypt. Egypt. J. Haematol 1988; 13(3-4):167-188.
22. Khalifa AS, Mokhtar GM, Ai OF et al. Behaviour of acute childhood leukemia in Egypt. Egypt J Oncol 1982; 2:27.
23. Miller DR, Kraile M, Blever WA et al. Prognostic implications of blast cells morphology in childhood acute lymphoblastic leukemia. A report from the Children's Cancer Study Group. Cancer Treat Rep 1985; 69:1211-1281.
24. Van Eys J, Pullen J, Head D, et al. The French American British (FAB) classification of leukemia. The paediatric Oncology Group Experience with lymphocytic leukemia. Cancer 1986; 57:1046-1052.
25. Miller DR, Leikin S, Albo V, Sather H, Hammond D. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol 1981; 48(2):199-206.
26. Lilleyman JS, Hann IM, Stevens RF, Eden OB, Richards SM. French American British (FAB) morphological classification of childhood lymphoblastic leukemia and its clinical importance. J Clin Pathol 1986; 39(9):998-1002.
27. Pui CH, Raimondi SC, Crist WM. Chromosomal abnormalities in childhood acute lymphoblastic leukemia. In Hoffbrand AV and Brenner, MK, eds. Recent Advances in Hematology. 6th edition. Chap 5, Churchill Livingstone Edinburgh London; Madrid Melbourne New York and Tokyo, 1992; 89-105.
28. Secker-Walker LM, Lawler SD, Hardisty RM. Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br Med J 1978; 2(6151):1529-1530.
29. Pui CH. Grist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76:1449-1463.
30. Kaneko Y, Rowley JD, Veriajojis D et al. Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res. 1982; 42:2918.
31. Fletcher JA, Kimball VM, Lynch E et al. Prognosis implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 1989; 74:2130.
32. Kobayashi H, Maseki N, Homma C et al. Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia 1994; 8(11):1930-1944.
33. Hafez M, Mansour AK, Mahmoud LA et al. Clinical significance of chromosome abnormalities in children with acute lymphoblastic leukemia. Egypt J Haematol 1999; 24:150-154.
34. Rowley JD, Reshmi S, Carlson K et al. Spectral karyotype analysis of T-cell acute leukemia. Blood 1999; 93:2038.
35. Viehmann S, Borkhardt A, Lampert F et al. Multiplex PCR a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia. Ann Hematol 1999; 78:157.
36. Bloomfield CD, Lindquist LL, Arthur D et al. Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res 1981; 41:4838.
37. Secker-Walker LM, Swansbury GJ, Lawler SD. Cytogenetics of acute lymphoblastic leukemia in children as a factor in prediction of long-term survival. Br J Hematol 1982; 52:389.
38. Michallef-Eynaud PD, Eden OB, Grace E et al. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1993; 10:25.
39. Heerma NA, Nachman JB, Sather HN et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 1999; 94(12):4036-4045.
40. Bloomfield CD, Secker-Walker LM. And Goldman AI. Six year follow up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40:171-189.
41. Secker-Walker L.M. and Goldman JM. Cytogenetics and leukemogenesis. In Hoffbrand AV. and Lewis SM, eds. Postgraduate Hematology. 3rd edition. Heineman Professional Publishing LTD, 1989; P:359.
42. Ito C, Kumagai M, Manabe A et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999; 93(1):315-320.
43. Mehdipour P, Mirfakhraie R, Jahani M, Mehdipour AR. Karyotypic evolution: cytogenetics follow-up study in childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev 2003; 4(4):358-368.
44. Nordgren A, Nordenskjld M, Mac Donald A et al. A case of acute lymphoblastic leukemia, near-triploidy, and poor outcome. Cancer Genet Cytogenet 1997; 99(2):93-96.
45. Zemanova Z, Michalova K, Sindelarova L et al. Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia. Leuk Res 2005; 29(3):273-281.
46. Stark B, Jeison M, Gobuzov R et al. Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: detection by fluorescence in situ hybridization. Cancer Genet Cytogenet 2001; 128(2):108-113.
47. Harrison CJ, Moorman AV, Broadfield ZJ et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia. Br J Hematol 2004; 125(5):552-559.
48. Harris MB, Shuster JJ, Andrew SA et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure. A pediatric Oncology Group Study. Blood 1992; 79:3316-3324.
49. Watson MS, Carrell AJ, Shuster JJ et al. Trisomy 21 in Childhood acute lymphoblastic leukemia. A pediatric Oncology Group Study. Blood 1993; 82:3098-3102.
50. Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet 1997; 94(1):8-12.
51. Williams DL, Harber J, Murphy SB et al. Chromsomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 1986; 68:205.
52. Williams DL, Harris A, Williams KG et al. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13:239.
53. Morrison-Delap S. and BS UW. Waisman center cytogenetics Laboratory (edited from "Cancer Cytogenetics", S. Heim, F Mitelman (2nd edition), from internet April 3, 2000.
54. Hafez M, El-Tahan H, El-Morsi Z et al. Genetic environmental interaction in acute lymphatic leukemia. In Muller HJ, Weber W, eds. Familial Cancer. Basel, Munchen, Paris, London, New York, New Delhi, Singapore, Tokyo, Sidney, Publication; 1985; Pp 161-166.
55. Pui CH. Childhood leukemias. N Engl J Med 1995; 332:1618.
56. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88:2375.
57. Bartolo C and Viswanatha D.S. Molecular Diagnosis in pediatric acute leukemia. Clinics of North America 2000; 20:139-156.
58. Ariffin H, Chen SP, Wong HL, Yeoh A. Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukaemia. Singapore Med J 2003; 44(10):517-520.
59. Kantarjian HM, Diesseroth A, Kurzrock M et al. Chronic myelogenous leukemia: a Concise up-date. Blood 1993; 82:691.
60. Foroni L, Harrison CJ, Hoffbrand AV et al. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis. Br J Haematol 1999; 105(1):7-24.
61. Baker SJ, Fearon ER, Wilson JKV et al. Suppression of human colorectal carcinoma cell growth by wild-type P53. Science 1990; 249:912.
62. Wada M, Bartram C, Nakamura H, et al. Analysis of P53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993; 82:3163.
63. Maroni G. Cancer. A genetic disease in Molecular and Genetic analysis of Human traits. Chapter 8, 2001; Pp 229-230.
64. Crist WM, Carroll AJ, Shuster JJ et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 1990; 76:117-122.
65. Chen CS, Sorensen PH, Domer PH et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993; 81:2386-2393.
66. Behm FG, Raimondi SC, Frestedt JL et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 87:2870-2877.